G01N 2333/4721
Cationic antimicrobial peptides
Official title: Cationic antimicrobial peptides, e.g. defensins
G01N2333/4721 (Cationic antimicrobial peptides) appears on 33 US grants and 48 published applications in this corpus.
Search patents in G01N- Granted patents
- 33
- Published applications
- 48
- Assignees
- 46
- Inventors
- 130
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 1 |
| 2002 | 0 | 2 |
| 2003 | 0 | 0 |
| 2004 | 0 | 4 |
| 2005 | 1 | 1 |
| 2006 | 1 | 4 |
| 2007 | 1 | 2 |
| 2008 | 1 | 0 |
| 2009 | 1 | 2 |
| 2010 | 1 | 1 |
| 2011 | 1 | 1 |
| 2012 | 1 | 4 |
| 2013 | 2 | 2 |
| 2014 | 0 | 4 |
| 2015 | 2 | 2 |
| 2016 | 2 | 5 |
| 2017 | 3 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 2 |
| 2022 | 1 | 3 |
| 2023 | 0 | 2 |
| 2024 | 1 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immunotherapy markers18 Aug 2026US 12,710,426 B2Universiteit Antwerpen
- Epithelial cancer evaluation using beta defensin28 Jan 2025US 12,210,019 B2Case Western Reserve University
- Targeted HD5 antibody and assay methods for diagnosing and treating inflammatory bowel disease24 Dec 2024US 12,174,200 B2Meharry Medical College
- Lateral flow assay device6 Dec 2022US 11,519,910 B2Fibrotx Oü
- Epithelial cancer evaluation using beta defensin27 Oct 2020US 10,816,549 B2Case Western Reserve University
- Alpha defensin assay for diagnosing nosocomial ventriculitis11 Sep 2025US 2025/0283898 A1University of Maryland, Baltimore
- Targeted defa5 antibody and assay methods for diagnosing and treating inflammatory bowel disease24 Jul 2025US 2025/0237665 A1Meharry Medical College
- Methods for determining responsiveness to tyk2 inhibitors28 Nov 2024US 2024/0390369 A1Bristol-Myers Squibb Company
- Anti-microbial peptide (amp) signatures for diagnostics, stratification, and treatment of microbiome-associated disease21 Mar 2024US 2024/0094224 A1Yeda Research and Development Co. Ltd.
- Biomarkers Predictive of Atopic Dermatitis3 Aug 2023US 2023/0243848 A1
Most cited
By later US patents
- Antibiotic cryptdin peptides and methods of their use36US 5,422,424 AThe General Hospital Corporation · 1995
- Protein kinase B/Akt modulators and methods for the use thereof15US 7,220,539 B1The Salk Institute for Biological Studies · 2007
- Antibiotic cryptdin peptides and methods of their use13US 5,731,149 AThe Shriner's Hospital for Crippled Children · 1998
- Antibiotic cryptdin peptides and methods of their use9US 5,844,072 AUniversity of California · 1998
- Antibiotic cryptdin peptides and methods of their use7US 5,840,498 AThe Regents of the University of California · 1998